PHARMACORP RX INC (PCRX.CA) Stock Earnings Estimates
TSX-V:PCRX • CA71714X1050
0.45 CAD
0 (0%)
Last: Feb 27, 2026, 07:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.795M | 20.742M 257.94% | 54.251M 161.55% | 77.77M 43.35% | |||
| EBITDA YoY % growth | N/A | N/A | -1.298M | 705.99K 154.37% | 6.379M 803.55% | 11.918M 86.83% | |
| EBIT YoY % growth | -563.2K -2,025.28% | -578K -2.63% | -1.588M -174.79% | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | -27.41% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | 0.01 | 0.03 200.00% |
All data in CAD
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.00 | 0.00 |
| Revenue Q2Q % growth | 7.405M 68.33% | 10.401M 159.57% |
| EBITDA Q2Q % growth | 383.8K -40.78% | 699.93K 68.37% |
| EBIT Q2Q % growth | N/A | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 4.802M 334.83% | % | ||
| Q2 2025 Q2Q % growth | 4.396M 1,408.48% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |